Gerald Anthony Reynolds - 21 Aug 2022 Form 4 Insider Report for APPLIED GENETIC TECHNOLOGIES CORP

Role: Chief Accounting Officer
Signature: /s/ Stacie Aarestad, Attorney-in-fact
Issuer symbol: N/A
Transactions as of: 21 Aug 2022
Net transactions value: $0
Form type: 4
Filing time: 24 Aug 2022, 20:21:27 UTC
Previous filing: 31 May 2022
Next filing: 01 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AGTC	Common Stock	Award	$0	+30,000	+143%	$0.000000	51,006	21 Aug 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted stock units ("RSUs") under the Applied Genetic Technologies Corporation ("AGTC") 2013 Equity and Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of AGTC common stock. The RSUs vest in two installments, with 50% vesting on August 21, 2023 and the remaining 50% vesting on August 21, 2024, subject to the Reporting Person's continued employment with or performance of services for the Company as of each vesting date.

Content

Represents a grant of restricted stock units ("RSUs") under the Applied Genetic Technologies Corporation ("AGTC") 2013 Equity and Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of AGTC common stock. The RSUs vest in two installments, with 50% vesting on August 21, 2023 and the remaining 50% vesting on August 21, 2024, subject to the Reporting Person's continued employment with or performance of services for the Company as of each vesting date.